Real‐World Clinical Data‐Driven Modeling Reveals Kinetic Concordance Between ALT/HBsAg Ratio and HBsAg Seroclearance in Chronic HBV Infection Patients
Journal of Medical Virology · 2026-11 · 98 (11)
DOI: 10.1002/jmv.71213 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 16.11.2026. Verfasst von Qiulin Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Mathematics and Statistics, Southwest University, Chongqing, China. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B Surface Antigens, Alanine Transaminase. Die Arbeit nennt 45 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
ALT/HBsAg ratio has been proposed as a predictor of HBsAg seroclearance in chronic HBV infection patients, yet its relationship to the underlying within‐host kinetics of HBsAg clearance remains undefined. Using a public longitudinal cohort of 1,131 patients and a dual model coupling HBV DNA and HBsAg apparent kinetics, we enrolled 277 patients with ideal HBsAg response within 12 weeks to estimate the apparent HBsAg clearance rate. Among them, 46 patients with biphasic HBV DNA decline were used to estimate the apparent HBV virions clearance rate, and of these, 16 HBeAg‐positive patients were used for exploratory estimation of other apparent parameters. Association between these apparent parameters and the ALT/HBsAg ratio were analyzed. Median apparent half‐lives were 1.16 days (range: 0.26–8.54) for HBV virions, 15.64 days (range: 1.70–80.31) for HBsAg, and 21.39 days (range: 3.09–219.78) for infected hepatocytes. Higher baseline ALT/HBsAg (HR: 1.009, 95% CI: 1.003–1.014) and higher apparent HBsAg clearance rate (adjusted HR: 1.090, 95% CI: 1.066–1.115) were independently associated with optimal response, with almost identical predicted survival functions. Significantly higher HBsAg apparent clearance rates were observed in HBeAg‐negative patients and those with low‐level viremia, higher ALT/HBsAg ratios, and achieving optimal response. An inverted V‐shaped pattern was identified in HBsAg stratification. This discovery‐phase study finds that the ALT/HBsAg ratio is closely associated with model‐derived apparent HBsAg clearance kinetics and is concordant with treatment outcome, providing a kinetic interpretation for its clinical predictive relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Mathematics and Statistics, Southwest University, Chongqing, China.
- Department of Hypertension and Endocrinology, Daping Hospital, Chongqing Institute of Hypertension, Army Medical University, Chongqing, China.
- Public Health Hospital of Southwest University, Chongqing, China.
- Department of Infectious Diseases, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, China.
ORCID-Profile: Qiang Li, Kaifa Wang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Huang, Q., Li, Q., Wang, Y., Wang, K., & Huang, G. (2026). Real‐World Clinical Data‐Driven Modeling Reveals Kinetic Concordance Between ALT/HBsAg Ratio and HBsAg Seroclearance in Chronic HBV Infection Patients. Journal of Medical Virology, 98(11). https://doi.org/10.1002/jmv.71213
Vancouver
Huang Q, Li Q, Wang Y, Wang K, Huang G. Real‐World Clinical Data‐Driven Modeling Reveals Kinetic Concordance Between ALT/HBsAg Ratio and HBsAg Seroclearance in Chronic HBV Infection Patients. Journal of Medical Virology. 2026;98(11). doi:10.1002/jmv.71213
BibTeX
@article{Huang2026,
author = {Huang, Qiulin and Li, Qiang and Wang, Yuming and Wang, Kaifa and Huang, Guangyu},
title = {Real‐World Clinical Data‐Driven Modeling Reveals Kinetic Concordance Between ALT/HBsAg Ratio and HBsAg Seroclearance in Chronic HBV Infection Patients},
journal = {Journal of Medical Virology},
year = {2026},
volume = {98},
number = {11},
doi = {10.1002/jmv.71213}
}
EUVIMED